Become A Featured Company

Chew On This: Hemptown Brings New CBD/CBG Gum to U.S. and Canadian Markets

Ash Stringer

December 11th, 2019

App, Exclusive, News, Top Story

 

With legalization of marijuana and hemp sweeping across North America, innovators are looking to pack the goodness of cannabis compounds into all sorts of consumer products, including chewing gum. Cannabinoid-infused gum is growing in popularity as consumers embrace the ease of transportation, precise dosing and rapid uptake to realize therapeutic effect. On the back of an acquisition this summer, multistate hemp grower Hemptown USA has taken a leadership position in the space, recently launching the first-ever hybrid CBD and CBG-infused gum.

 

 

The Acquisition at the Backbone of it All

In July, the hemp startup and subsidiary of Hemptown Organics Corp. acquired longtime nutraceutical maker Kirkman Group for the purpose of accelerating its entrance into the consumer packaged goods sector. Lake Oswego, Oregon-based Kirkman has been in business for 70 years with over 400 products in its portfolio and a specialty in supplying world-class formulations for children with autism and special needs.

The acquisition gave Hemptown a bevy of assets along with the product bag. These included a 25,000-square-foot FDA-licensed, cGMP (Current Good Manufacturing Practice) manufacturing facility, the Ultra Tested® test protocols, a highly seasoned and well-respected staff and management team, library of state-of-the-art formulations and appropriate equipment to manufacture a wide array of CBD and CBG liquid fill tinctures, creams, topicals, and gums/edibles.

Accredited? Click here to get more information on Hemptown USA’s pre-public financing.

Global (Yes, Global) Leader in CBG

In the acronym-filled cannabis space, CBD (cannabidiol) and THC (tetrahydrocannabinol) are the two most talked about cannabis components, but neither would be possible if it weren’t for the lesser known CBG (cannabigerol). CBG is colloquially known as the “Mother of All Cannabinoids” because it is a precursor to THC and CBD and many other cannabinoids. To the point that it converts into other compounds, CBG only presents in limited amounts in cannabis and its non-intoxicated cousin hemp.

When the 2018 U.S. Farm Bill was passed late in 2018, hemp – which by definition contains little to no THC (the part of cannabis responsible for the “high”) – became legal across the U.S., paving the way for interstate commerce for cannabinoid-bearing products derived from hemp.

More research needs to be completed, but indications exists that CBG can be effective in treating glaucoma (as a vasodilator), IBD (as an anti-inflammatory), Huntington’s disease (because of neuro-protective qualities), infections (as an antibiotic), cancer and many other elusive maladies.

Leveraging market-leading seed genetics that support increased CBG levels in hemp plants, Hemptown is growing over 500 acres specifically focused on making the company the dominant North American supplier of CBG.

It’s already checking that box. This latest cultivation season, Hemptown scaled up to grow the single largest crop of CBG not only in its home state of Oregon, but in the world.

Accredited? Click here to get more information on Hemptown USA’s pre-public financing.

Now Bring the Gum

The first consumer product innovation to come out of the acquisition of Kirkman is Hemptown Chew gum, which contains the highest level of hemp-derived CBD and CBG cannabinoids on the market today. Each piece of Hemptown Chew mint-flavored gum contains 15 milligrams of CBD and 5 milligrams of CBG.

Along with the potential benefits of CBG, chewers of Hemptown’s gum may also enjoy the rewards of CBD, which is widely touted for supporting joint and muscle function (and recovery), aiding with restful sleep, promoting healthy skin and reducing anxiety, amongst many other things.

As it happens, chewing gum has been shown to improve alertness, so those that are looking to benefit from the mental acuity often attributed to CBD could get more bang for their buck.

 

 

Hemptown is hoping to capture a share of the global chewing gum market Mordor Intelligence forecasts to keep growing 4.3% annually to reach $22.27 billion by 2024. With sales of sugared chewing gums on the decline, Mordor analysts expect functional chewing gums to be a market driver.

“We are looking forward to growing and expanding in the U.S., as we believe there is a great opportunity for functional gums and their benefits – especially knowing that global consumption of hemp-infused products is growing exponentially,” said Bruce Trent, VP global sales, Hemptown USA, in a statement on the new product launch.

Accredited? Click here to get more information on Hemptown USA’s pre-public financing.

The Hemptown gum began its roll-out across the U.S. during October. The company is coming in at a price point that is attractive compared to other cannabinoid-bearing gums. As it works its way onto retailers’ shelves, the gum can be bought online on HemptownUSA.com. A single pack containing two servings is $4.99, a pack of six is $9.99, and a pack of 12 is $18.99.

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://cannabisfn.com(the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ash Stringer

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading